Major Startup Accelerators Worldwide, and How to Choose
A survey of well-known accelerator programs, what distinguishes them, and a framework for deciding which - if any - is worth the equity for your specific business.
Verify current terms. Program structures, investment amounts and equity percentages change frequently. Everything below is directional; check each program's own site before applying.
The landscape
Accelerators fall into a few distinct types, and confusing them is the main reason founders apply to the wrong ones.
Generalist, high-signal programs. Y Combinator being the obvious example. Sector-agnostic, extremely selective, standardised terms, very strong alumni networks. Value concentrated in signal and network.
Networked multi-city programs. Techstars operates numerous programs across many cities and verticals. More accessible than the very top tier, with local networks that vary considerably in strength by location and by managing director. The specific program matters far more than the brand.
Company-builder models. Antler and similar programs admit individuals as well as teams, help form founding teams, and then invest in the companies that emerge. Structurally different - useful if you do not yet have a co-founder, less relevant if you have a functioning team and a product.
Sector specialists. Programs focused on fintech, health, climate, deep tech, space. Smaller networks but far more relevant ones, and often with access to regulatory or industrial partners a generalist program cannot offer. For a regulated sector these are frequently the better choice.
Corporate accelerators. Run by large companies to access innovation in their sector. Typically offer distribution, pilot opportunities and domain access rather than significant capital, and frequently take no equity. The value is a route to a customer that would otherwise take two years to reach. The risk is becoming dependent on a single corporate relationship.
Government and institution-linked programs. In India, a substantial amount of early-stage support flows through recognised incubators under government schemes, frequently without equity. Covered in more detail in the schemes posts in this series.
University accelerators. Attached to institutions, usually for students and alumni, often non-dilutive, generally with facilities.
What actually differentiates them
Not the curriculum. Most accelerator curricula cover broadly similar ground, and much of it is freely available.
The real differentiators:
Network relevance. Not size - relevance. A program with 500 alumni in enterprise SaaS is worth more to an enterprise SaaS company than one with 5,000 alumni across every sector. Ask specifically: who in your alumni network sells to the customers I need to reach?
Investor access, and whose. Which investors actually attend demo day, and do they invest at your stage in your geography? A demo day full of US seed funds is of limited use if you need Indian investors who understand your market.
The specific people running it. In multi-program organisations, quality varies substantially between locations. The managing director of your specific program matters more than the brand on the door.
Whether they can open a door you cannot. A corporate accelerator that gets you a pilot with a large bank has provided something you could not have bought. A program that provides mentorship and a co-working desk has provided something you could.
A framework for deciding
Work through these in order.
1. What is your actual binding constraint?
Be specific. Capital? Investor access? A particular kind of customer? A co-founder? Domain credibility in a regulated sector?
If you cannot name the constraint, you are considering an accelerator for validation, and validation is expensive at 7%.
2. Does this program remove that specific constraint?
Not "is it a good program" but "does it solve my problem". A superb generalist accelerator does not solve a regulatory access problem.
3. What is the true cost?
Equity, plus relocation, plus three months of your attention, plus any obligations that continue afterwards - right of first refusal on your next round, information rights, board observer seats.
Model the equity properly. 7% taken pre-seed, after full dilution through a Series B, represents a large absolute value if the company succeeds. That is not an argument against it; it is an argument for being clear about what you are paying.
4. Talk to alumni - including the failures
The most important step, and the one most often skipped.
Contact three alumni directly, not through the program. Include at least one whose company did not succeed. Ask:
- What did you actually get, concretely?
- What was oversold?
- Did you raise afterwards, and did the program cause it?
- Would you do it again?
- Who from the network do you still speak to?
The founder whose company failed will tell you what the program delivered without the incentive to be positive. That conversation is worth more than any amount of research.
5. Check the terms as carefully as a term sheet
Equity percentage, instrument, valuation cap, pro-rata rights, information rights, right of first refusal, any exclusivity. Some programs include terms that materially constrain your next round.
For Indian founders
Two considerations that change the calculation.
Restructuring. Several international programs require reorganising into a US or Singapore entity. For an Indian company this has real tax, regulatory and compliance consequences, and it interacts with any existing Indian shareholders and any scheme-linked funding you have received. Get specialist advice before accepting, not after.
Market alignment. If your customers are Indian, an Indian network is usually more valuable than a US one. Founders sometimes optimise for the prestige of a US program and then discover that its network cannot help them sell in India or raise from Indian funds.
The counter-argument holds when you are genuinely building for global markets and intend to raise from US investors - in which case the network is the point and the restructuring is a cost of accessing it.
When the answer is no
It is worth saying plainly: for many companies, no accelerator is the right answer.
If you have a product, paying customers, a functioning team and access to investors, an accelerator is unlikely to add 7% of value. If your binding constraint is a customer, the fastest route is to go and get the customer.
The founders who benefit most are those with a specific, identifiable gap that a specific program demonstrably fills.
The one-line summary
Accelerators differ on network relevance, investor access and the specific people running your program - not on curriculum. Identify your binding constraint first, check whether a given program actually removes it, read the terms as carefully as a term sheet, and talk to alumni whose companies failed. For Indian founders, weigh network alignment against the real cost of restructuring.
Frequently asked questions
- Which accelerator is best for an Indian startup?
- It depends on your market. If you are selling primarily to Indian customers, an India-based program with a domestic network is usually more useful than a US program requiring restructuring. If you are targeting global markets and intend to raise from US investors, a US program's network may justify the complexity.
- How much equity do accelerators take?
- Commonly 5–10% for an investment in the range of tens of thousands to a few hundred thousand dollars, though terms vary widely. Some corporate and government-linked programs take no equity at all. Always read the actual terms rather than the advertised headline.
- Are accelerators worth the equity?
- Sometimes. The equity is taken at the cheapest point in your company's life, so it is expensive in expectation. It is worth it when the program removes your actual binding constraint - usually investor access or a specific network - and not worth it when you are joining for validation.
